 |
 |
Therabel |
Coruno® |
molsidomine |
Angina |
Marketed |
Ratiopharm |
diclofenac-ratiopharm-uno |
diclofenac |
Arthritis |
Marketed |
Roche |
Madopar DR® |
levodopa/benserazide |
Parkinson's disease |
Marketed |
GlaxoSmithKline |
Paxil CR™ |
paroxetine |
CNS |
Marketed |
GlaxoSmithKline |
Requip® once-a-day(EU) |
ropinirole |
Parkinson's disease |
Approved |
Sciele Pharma |
Triglide® |
fenofibrate |
Cardiovascular |
Marketed |
Sanofi-Aventis |
Xatral® OD/Uroxatral® |
alfuzosin |
BPH(urinary symptoms)± |
Marketed |
Critical Therapeutics |
ZYFLO CR™ |
zileuton |
Asthma |
Marketed |
Nitec |
Lodotra™ |
prednisone |
Pain/Inflammation |
Filed |
Sciele Pharma |
sular® |
nisoldipine |
Hypertension |
Marketed |
Somnus Therapeutics |
SKP-1041 |
undisclosed |
Sleep disorders |
Phase I |
Available |
SKP-1032 |
undisclosed |
Pain/inflammation |
Phase I |
|
 |
Novartis |
Foradil® Certihaler™ |
formoterol |
Asthma |
Approved |
AstraZeneca |
Pulmicort® HFA-MDI |
budesonide |
Asthma |
Marketed |
Abbott/Mundipharma |
Flutiform™ |
formoterol/fluticasone |
Asthma/COPD |
Phase III |
|
 |
Nycomed/Almirall |
Solaraze® |
diclofenac |
Actinic keratosis |
Marketed |
|
|